Blank Cover Image

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease

フォーマット:
論文
責任表示:
Tada, Hayato ; Nohara, Atsushi ; Inazu, Akihiro ; Sakuma, Nagahiko ; Mabuchi, Hiroshi ; Kawashiri, Masa-aki ; 多田, 隼人 ; 野原, 淳 ; 稲津, 明広 ; 馬淵, 宏 ; 川尻, 剛照
言語:
英語
出版情報:
日本動脈硬化学会 = Japan Atherosclerosis Society, 2018
著者名:
Tada, Hayato
Nohara, Atsushi
Inazu, Akihiro
Sakuma, Nagahiko
Mabuchi, Hiroshi
Kawashiri, Masa-aki
多田, 隼人
野原, 淳
稲津, 明広
馬淵, 宏
川尻, 剛照
続きを見る
掲載情報:
Journal of Atherosclerosis and Thrombosis
ISSN:
1340-3478  CiNii Research  Webcat Plus  JAIRO
巻:
25
通号:
9
開始ページ:
783
終了ページ:
789
バージョン:
publisher
概要:
金沢大学附属病院循環器内科<br />Sitosterolemia is a rare inherited disease characterized by increased levels of plant sterols, such as sitosterol. The cause of this disease is ATP-binding cassette (ABC) subfamily G member 5 or member 8 (ABCG5 or A BCG8, respectively) gene mutations. Recent advances in genetics have revealed that the prevalence of subjects with deleterious mutations in ABCG5 and/or ABCG8 genes could be more than 1 in ~200,000 individuals among the general population. Furthermore, accumulated evidence, including infantile cases exhibiting progression/regression of systemic xanthomas associated with LDL cholesterol levels, have shown that the elevation of LDL cholesterol seems to be the major cause of development of atherosclerosis and not the elevation of sitosterol. Regarding therapies, LDL apheresis, as well as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, could be useful for sitosterolemia, in addition to ezetimibe and/or colestimide. In this study, we provide the current understanding and future perspectives of sitosterolemia, which is currently considered an extremely rare disorder but is expected to be much more prevalent in clinical settings.<br />This article distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. 続きを見る
URL:
http://hdl.handle.net/2297/00053008
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Tada, Hayato, Kawashiri, Masa-aki, Okada, Hirofumi, Endo, Saori, Toyoshima, Yuka, Konno, Tetsuo, Nohara, Atsushi, Inazu, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Tsuchida, Masayuki, Kawashiri, Masa-aki, Tada, Hayato, Takata, Mutsuko, Nohara, Atsushi, Ino, Hidekazu, Inazu, Akihiro, &hellip;

Japanese Circulation Society = 日本循環器学会

Tada, Hayato, Nomura, Akihiro, Nohara, Atsushi, Inazu, Akihiro, Mabuchi, Hiroshi, YAMAGISHI, Masakazu, Kawashiri, &hellip;

日本動脈硬化学会 = Japan Atherosclerosis Society

Tada, Hayato, Kawashiri, Masa-aki, Yamagishi, Masakazu, 多田, 隼人, 川尻, 剛照, 山岸, 正和

日本動脈硬化学会 = Japan Atherosclerosis Society

Nomura, Akihiro, Tada, Hayato, Nohara, Atsushi, Kawashiri, Masa-aki, Yamagishi, Masakazu, 野村, 章洋, 多田, &hellip;

日本動脈硬化学会 = Japan Atherosclerosis Society

Nozue, Tsuyoshi, Kawashiri, Masa-aki, Higashikata, Toshinori, Nohara, Atsushi, Inazu, Akihiro, Kobayashi, Junji, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Tada, Hayato, Kawashiri, Masa-aki, Nohara, Atsushi, Inazu, Akihiro, Kobayashi, Junji, Mabuchi, Hiroshi, Yamagishi, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Tada, Hayato, Kobayashi, Junji, Kawashiri, Masa-aki, Miyashita, Kazuya, Nohara, Atsushi, Inazu, Akihiro, Nakajima, &hellip;

BioMed Central

Tada, Hayato, Nohara, Atsushi, Kawashiri, Masa-aki, Inazu, Akihiro, Mabuchi, Hiroshi, Yamagishi, Masakazu, 多田, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashia, Kenshi, &hellip;

Elsevier Science Ireland

Tada, Hayato, Kawashiri, Masa-aki, Yoshida, Taiji, Teramoto, Ryota, Nohara, Atsushi, Konno, Tetsuo, Inazu, Akihiro, &hellip;

Japanese Circulation Society = 日本循環器学会

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashi, Kenshi, &hellip;

Elsevier